epigallocatechin gallate has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hazawa, M; Kashiwakura, I; Sugata, S; Takahashi, K | 1 |
Jalili, A; Janowska-Wieczorek, A; Korol, C; Lee, H; Marquez-Curtis, L; Qiu, Y; Ratajczak, MZ; Shirvaikar, N; Turner, AR | 1 |
2 other study(ies) available for epigallocatechin gallate and Diffuse Mixed Small and Large Cell Lymphoma
Article | Year |
---|---|
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
Topics: Apoptosis; Caspase 3; Catechin; HL-60 Cells; Humans; K562 Cells; Lymphoma, Non-Hodgkin; Molecular Structure; Reactive Oxygen Species; Receptors, Laminin; Stereoisomerism | 2011 |
Fifth complement cascade protein (C5) cleavage fragments disrupt the SDF-1/CXCR4 axis: further evidence that innate immunity orchestrates the mobilization of hematopoietic stem/progenitor cells.
Topics: Animals; Catechin; Cells, Cultured; Chemokine CXCL12; Chemotaxis; Complement C5; Complement C5a; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Gene Expression Regulation; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Humans; Immunity, Innate; Lymphoma, Non-Hodgkin; Mice; Peptide Fragments; Receptor, Anaphylatoxin C5a; Receptors, CXCR4; Up-Regulation | 2010 |